Aviron (Acquired by MedImmune, Inc.)
Press releases archived for reference only.
Mountain View
California
U.S.A.
Phone:
n/a
Fax:
n/a
|
Aviron is a biopharmaceutical company based in Mountain View, CA focused on prevention of disease. The company's goal is to develop products which offer cost-effective prevention of a wide range of infections that affect the general population. The majority of Aviron's products under development are live vaccines against viral infections. These include intranasal vaccines for respiratory infections and their complications - influenza [FluMist(TM)], parainfluenza (PIV-3), and respiratory syncytial virus (RSV), and injectable vaccines to prevent cytomegalovirus (CMV) and genital herpes (HSV-2). Aviron is also developing, in collaboration with SmithKline Beecham Biologicals, a subunit vaccine against Epstein-Barr Virus (EBV) infection, a major cause of infectious mononucleosis.
Last Updated:12-03-01
Email:
Ownership:
Web Site:
Aviron (Acquired By MedImmune, Inc.)
Employees:
Symbol: MEDI
|